Fuji Pharma Co Ltd
FUP
Company Profile
Business description
Fuji Pharma Co Ltd is involved in the development, manufacture, and marketing of pharmaceutical products, such as injection agents, internal drugs, drugs for external use, and diagnostic products. The group consists of a single segment, the pharmaceutical business.
Contact
5-7 Sanban-cho
Chiyoda-ku
Tokyo102-0075
JPNT: +81 335563344
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
30 September 2026
Employees
1,760
Stocks News & Analysis
stocks
Ahead of an IPO, the maths behind Databrick’s $190 billion valuation doesn’t add up
The data and AI company is one of the world’s strongest private companies, but a PitchBook report says it’s unattractive at the current price.
stocks
Takeover proposal agreed for ASX share, other offers permitted
Morningstar analysts’ take on the takeover for this undervalued industrial player.
stocks
Our top ASX picks in every sector
These companies are our favourite choices for investors wanting to boost Aussie equity exposure.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,922.20 | 0.50 | -0.01% |
| CAC 40 | 8,065.02 | 121.91 | -1.49% |
| DAX 40 | 25,304.06 | 412.65 | -1.60% |
| Dow JONES (US) | 51,682.64 | 95.40 | -0.18% |
| FTSE 100 | 10,659.13 | 157.01 | -1.45% |
| HKSE | 24,911.54 | 160.76 | 0.65% |
| NASDAQ | 26,522.54 | 104.25 | 0.39% |
| Nikkei 225 | 65,018.95 | 882.70 | 1.38% |
| NZX 50 Index | 13,802.30 | 63.16 | 0.46% |
| S&P 500 | 7,650.50 | 12.74 | 0.17% |
| S&P/ASX 200 | 8,733.70 | 2.50 | 0.03% |
| SSE Composite Index | 3,931.83 | 19.96 | 0.51% |